Cargando…

Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population‐Based Cohort Study

BACKGROUND: Atherosclerotic disease is an important contributor to adverse outcomes in patients with atrial fibrillation (AF). There is limited recognition of the association between statin use and stroke rates in AF. We aimed to quantify the association between statin use and stroke rate in AF. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shweikialrefaee, Bisan, Ko, Dennis T., Fang, Jiming, Pang, Andrea, Austin, Peter C., Dorian, Paul, Singh, Sheldon M., Jackevicius, Cynthia A., Tu, Karen, Lee, Douglas S., Abdel‐Qadir, Husam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356038/ https://www.ncbi.nlm.nih.gov/pubmed/37318025 http://dx.doi.org/10.1161/JAHA.122.028381

Ejemplares similares

Validation of the Use of Discharge Diagnostic Codes for the Verification of Secondary Atrial Fibrillation in Administrative Databases
por: Nakajima, Erika, et al.
Publicado: (2023)

Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
por: Abdel‐Qadir, Husam, et al.
Publicado: (2022)

Population Trends in All‐Cause Mortality and Cause Specific–Death With Incident Atrial Fibrillation
por: Singh, Sheldon M., et al.
Publicado: (2020)

Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation
por: Abdel-Qadir, Husam, et al.
Publicado: (2018)

Prescribing of two potentially interacting cardiovascular medications in atrial fibrillation patients on direct oral anticoagulants
por: Shurrab, Mohammed, et al.
Publicado: (2021)

Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study
por: Abdel-Qadir, Husam, et al.
Publicado: (2022)

Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery
por: Ge, Yin, et al.
Publicado: (2017)

Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation
por: Abdel-Qadir, Husam, et al.
Publicado: (2019)

The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study
por: Abdel-Qadir, Husam, et al.
Publicado: (2022)

Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction
por: Edwards, Jodi D., et al.
Publicado: (2020)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

Effect of statin use on clinical outcomes in ischemic stroke patients with atrial fibrillation
por: Wu, Yi-Ling, et al.
Publicado: (2017)

Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation
por: Choi, Kang‐Ho, et al.
Publicado: (2019)

Assessment of an Algorithm for Prescription of Oral Anticoagulation for Patients With Atrial Fibrillation in Emergency Departments
por: Atzema, Clare L., et al.
Publicado: (2020)

Hospital‐Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome
por: Ozaki, Aya F., et al.
Publicado: (2022)

Statin Effects in Atrial Fibrillation-Related Stroke: A Systematic Review and Meta-Analysis
por: Eun, Mi-Yeon, et al.
Publicado: (2020)

Projected Real‐World Effectiveness of Using Aggressive Low‐Density Lipoprotein Cholesterol Targets Among Elderly Statin Users Following Acute Coronary Syndromes in Canada
por: Alter, David A., et al.
Publicado: (2018)

Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study
por: Abdel‐Qadir, Husam, et al.
Publicado: (2021)

Association of Cardiology Billing Amounts With Health Care Utilization and Clinical Outcomes in Patients With Atrial Fibrillation
por: Bhatia, R. Sacha, et al.
Publicado: (2021)

Pleiotropic effects of statins in atrial fibrillation patients: the evidence
por: Hadi, Hadi AR, et al.
Publicado: (2009)

Identifying Predictors of Cumulative Healthcare Costs in Incident Atrial Fibrillation: A Population‐Based Study
por: Bennell, Maria C., et al.
Publicado: (2015)

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
por: Halperin, Jonathan L, et al.
Publicado: (2014)

Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis
por: Kotlęga, Dariusz, et al.
Publicado: (2019)

Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
por: Udell, Jacob A., et al.
Publicado: (2022)

Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke
por: Hu, Wei-Syun, et al.
Publicado: (2023)

Statins and SARS‐CoV‐2 Infection: Results of a Population‐Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces
por: McAlister, Finlay A., et al.
Publicado: (2021)

Prescribing patterns and factors associated with sodium–glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease
por: Ozaki, Aya F., et al.
Publicado: (2023)

Pre-Stroke Statin Therapy Improves In-Hospital Prognosis Following Acute Ischemic Stroke Associated with Well-Controlled Nonvalvular Atrial Fibrillation
por: Wańkowicz, Paweł, et al.
Publicado: (2021)

Trial design, statins, atrial fibrillation, and prevention: Four horsemen of the apocalypse
por: Koza, Yavuzer, et al.
Publicado: (2015)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
por: Kim, Bum Joon, et al.
Publicado: (2021)

Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction
por: Ko, Dennis, et al.
Publicado: (2019)

Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy
por: Wijeysundera, Harindra C, et al.
Publicado: (2017)

Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial
por: Lee, Theresa M., et al.
Publicado: (2016)

Statins in paroxysmal atrial fibrillation: Beneficial to prevent recurrence but insufficient to stop progression
por: Polovina, Marija M.
Publicado: (2017)

Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects
por: Nomani, Homa, et al.
Publicado: (2021)

The importance of statin therapy in atrial fibrillation patients independent of CHADS-VASc score
por: Akşit, Ercan, et al.
Publicado: (2023)

Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation
por: Tawfik, Amy, et al.
Publicado: (2016)

High prevalence of atrial fibrillation among Greenlanders with ischemic stroke – atrial fibrillation found in more than 30% of cases
por: Bjorn-Mortensen, Karen, et al.
Publicado: (2013)

Paroxysmal atrial fibrillation in cryptogenic stroke
por: Dangayach, Neha S, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b91g1955vb4vltboqhiu3hu9b9